Study of nerve tumors in children affecting the spine canal
Part of Brain & nervous system, Cancer clinical trials.
This study follows children and teens with certain nerve-cell tumors (like neuroblastoma) that involve the spinal canal. It collects information on how these tumors behave and how treatments and outcomes may differ, aiming to improve care over the long term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be under age 18 with a peripheral neuroblastic tumor (such as neuroblastoma, ganglioneuroblastoma, or ganglioneuroma).
- The tumor must involve the spinal canal (spinal canal involvement), with symptoms or no symptoms.
- You have not had chemotherapy in the past 6 months (steroids are allowed).
- You can commit to at least 5 years of follow-up visits or tracking.
- You will provide written consent from a parent/guardian and the patient (as required by the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.
This study creates an international registry linked to a virtual biobank, so researchers can collect and share information and biological samples for patients with specific peripheral neuroblastic tumors. It may help future research and care planning by improving what scientists know about these conditions.
This study looks at patterns in what adults with neuroblastoma experience during treatment and follow-up visits. It may help researchers understand what patients go through so care and support can improve.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This Phase 3 trial tests treatments for children and teens with high-risk neuroblastoma, aiming to improve outcomes by using biology-based risk information. It also requires limited prior chemotherapy and specific timing after diagnosis.
Hear when a new Neuroblastic Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.